Cargando…

F‐18 FDG PET‐CT for response evaluation in head and neck malignancy: Experience from a tertiary level hospital in south India

BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) accounts for 90% of head and neck cancers. There has been no established qualitative system of interpretation for therapy response assessment using PET‐CT for HNSCC. AIM: To assess response evaluation of nodal status in post‐treatment PET‐CT...

Descripción completa

Detalles Bibliográficos
Autores principales: Benjamin, Justin, Hephzibah, Julie, Shanthly, Nylla, Oommen, Regi, Mathew, David, Pavamani, Simon, Rajnikanth, Janakiraman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222552/
https://www.ncbi.nlm.nih.gov/pubmed/33660434
http://dx.doi.org/10.1002/cnr2.1333
_version_ 1783711506802671616
author Benjamin, Justin
Hephzibah, Julie
Shanthly, Nylla
Oommen, Regi
Mathew, David
Pavamani, Simon
Rajnikanth, Janakiraman
author_facet Benjamin, Justin
Hephzibah, Julie
Shanthly, Nylla
Oommen, Regi
Mathew, David
Pavamani, Simon
Rajnikanth, Janakiraman
author_sort Benjamin, Justin
collection PubMed
description BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) accounts for 90% of head and neck cancers. There has been no established qualitative system of interpretation for therapy response assessment using PET‐CT for HNSCC. AIM: To assess response evaluation of nodal status in post‐treatment PET‐CT scans in HNSCC using a 5‐point Likert scale (Deauville score [DS]). METHODS AND RESULTS: Retro‐prospective analysis was performed of the nodal status of pre and post‐RT PET‐CT in patients diagnosed with HNSCC (n = 43) from May 2013 to March 2018. All eligible patients underwent a pre‐RT PET‐CT scan before the start of RT. Another post‐RT PET‐CT scan was performed 12 weeks after the completion of RT. The median time from completion of radiotherapy (RT) to post‐RT PET‐CT was 92 days; 80% of the patients had their post‐RT PET‐CT scan between 77 and 147 days after therapy. Of 43 patients (M/33, F/10, age range 18 to 80 years (median 54 years) selected for the study, good concordance was noted between DS and clinical response in these patients. The change in SUV from pre‐RT PET to post‐RT PET was analyzed using a paired t‐test. The P‐value was found to be statistically significant while comparing pre and post‐RT SUVmax levels showing that RT had significantly reduced the SUVmax levels of the nodes in DS 2‐3 groups whereas the number of patients was too small to allow a reliable calculation in DS 4‐5 groups. It was found that 36/39 patients with DS 1‐3 had no nodal recurrence showing a high NPV of 92.3%. Of the four patients with DS 4‐5, all had active disease showing PPV of 100%. Applying Fisher's exact test, the P‐value was found to be .004. CONCLUSION: DS seems to satisfy the requirements for a simple qualitative method of interpreting PET scans and for identifying patients requiring neck dissection. Consensus regarding qualitative assessment would facilitate standardization of PET reporting in clinical practice and enable comparative multicentric studies
format Online
Article
Text
id pubmed-8222552
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-82225522021-06-29 F‐18 FDG PET‐CT for response evaluation in head and neck malignancy: Experience from a tertiary level hospital in south India Benjamin, Justin Hephzibah, Julie Shanthly, Nylla Oommen, Regi Mathew, David Pavamani, Simon Rajnikanth, Janakiraman Cancer Rep (Hoboken) Original Articles BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) accounts for 90% of head and neck cancers. There has been no established qualitative system of interpretation for therapy response assessment using PET‐CT for HNSCC. AIM: To assess response evaluation of nodal status in post‐treatment PET‐CT scans in HNSCC using a 5‐point Likert scale (Deauville score [DS]). METHODS AND RESULTS: Retro‐prospective analysis was performed of the nodal status of pre and post‐RT PET‐CT in patients diagnosed with HNSCC (n = 43) from May 2013 to March 2018. All eligible patients underwent a pre‐RT PET‐CT scan before the start of RT. Another post‐RT PET‐CT scan was performed 12 weeks after the completion of RT. The median time from completion of radiotherapy (RT) to post‐RT PET‐CT was 92 days; 80% of the patients had their post‐RT PET‐CT scan between 77 and 147 days after therapy. Of 43 patients (M/33, F/10, age range 18 to 80 years (median 54 years) selected for the study, good concordance was noted between DS and clinical response in these patients. The change in SUV from pre‐RT PET to post‐RT PET was analyzed using a paired t‐test. The P‐value was found to be statistically significant while comparing pre and post‐RT SUVmax levels showing that RT had significantly reduced the SUVmax levels of the nodes in DS 2‐3 groups whereas the number of patients was too small to allow a reliable calculation in DS 4‐5 groups. It was found that 36/39 patients with DS 1‐3 had no nodal recurrence showing a high NPV of 92.3%. Of the four patients with DS 4‐5, all had active disease showing PPV of 100%. Applying Fisher's exact test, the P‐value was found to be .004. CONCLUSION: DS seems to satisfy the requirements for a simple qualitative method of interpreting PET scans and for identifying patients requiring neck dissection. Consensus regarding qualitative assessment would facilitate standardization of PET reporting in clinical practice and enable comparative multicentric studies John Wiley and Sons Inc. 2021-03-03 /pmc/articles/PMC8222552/ /pubmed/33660434 http://dx.doi.org/10.1002/cnr2.1333 Text en © 2021 The Authors. Cancer Reports published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Benjamin, Justin
Hephzibah, Julie
Shanthly, Nylla
Oommen, Regi
Mathew, David
Pavamani, Simon
Rajnikanth, Janakiraman
F‐18 FDG PET‐CT for response evaluation in head and neck malignancy: Experience from a tertiary level hospital in south India
title F‐18 FDG PET‐CT for response evaluation in head and neck malignancy: Experience from a tertiary level hospital in south India
title_full F‐18 FDG PET‐CT for response evaluation in head and neck malignancy: Experience from a tertiary level hospital in south India
title_fullStr F‐18 FDG PET‐CT for response evaluation in head and neck malignancy: Experience from a tertiary level hospital in south India
title_full_unstemmed F‐18 FDG PET‐CT for response evaluation in head and neck malignancy: Experience from a tertiary level hospital in south India
title_short F‐18 FDG PET‐CT for response evaluation in head and neck malignancy: Experience from a tertiary level hospital in south India
title_sort f‐18 fdg pet‐ct for response evaluation in head and neck malignancy: experience from a tertiary level hospital in south india
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222552/
https://www.ncbi.nlm.nih.gov/pubmed/33660434
http://dx.doi.org/10.1002/cnr2.1333
work_keys_str_mv AT benjaminjustin f18fdgpetctforresponseevaluationinheadandneckmalignancyexperiencefromatertiarylevelhospitalinsouthindia
AT hephzibahjulie f18fdgpetctforresponseevaluationinheadandneckmalignancyexperiencefromatertiarylevelhospitalinsouthindia
AT shanthlynylla f18fdgpetctforresponseevaluationinheadandneckmalignancyexperiencefromatertiarylevelhospitalinsouthindia
AT oommenregi f18fdgpetctforresponseevaluationinheadandneckmalignancyexperiencefromatertiarylevelhospitalinsouthindia
AT mathewdavid f18fdgpetctforresponseevaluationinheadandneckmalignancyexperiencefromatertiarylevelhospitalinsouthindia
AT pavamanisimon f18fdgpetctforresponseevaluationinheadandneckmalignancyexperiencefromatertiarylevelhospitalinsouthindia
AT rajnikanthjanakiraman f18fdgpetctforresponseevaluationinheadandneckmalignancyexperiencefromatertiarylevelhospitalinsouthindia